Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Apr 5;356(14):1445-54.
doi: 10.1056/NEJMra065142.

Viral hepatitis in HIV infection

Margaret James Koziel  1 , Marion G Peters
Affiliations
Review

Viral hepatitis in HIV infection

Margaret James Koziel et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

No other potential conflict of interest relevant to this article was reported.

Figures

Figure 1
Figure 1. Deaths in a Cohort of 23,441 Patients Treated with Anti-HIV Drugs (Panel A) and Deaths from Liver Disease According to the CD4 Cell Count (Panel B)
The data are from the the Data Collection on Adverse Events of Anti-HIV Drugs Study, reported by Weber et al.
Figure 2
Figure 2. HBV Reverse-Transcriptase and Polymerase Mutations That Confer Resistance to HBV Therapies
The mutations are numbered according to the amino acid position in the polymerase and reverse transcriptase. The arrows denote the expansion of the polymerase or reverse transcriptase and show its various domains. The first nucleoside, rt1, corresponds to amino acid 349, and the last nucleoside, rt344, corresponds to amino acid 692. Patients who receive entecavir must have existing resistance to lamivudine. Tenofovir has not been approved for the treatment of HBV infection.
See this image and copyright information in PMC

Comment in

  • Viral hepatitis in HIV infection.
    Cross TJ, Taylor CB, Harrison PM. Cross TJ, et al. N Engl J Med. 2007 Jul 5;357(1):90; author reply 91. doi: 10.1056/NEJMc071236. N Engl J Med. 2007. PMID: 17611215 No abstract available.
  • Viral hepatitis in HIV infection.
    Leiner S. Leiner S. N Engl J Med. 2007 Jul 5;357(1):90; author reply 91. N Engl J Med. 2007. PMID: 17615640 No abstract available.
  • Viral hepatitis in HIV infection.
    Rendina D, Mossetti G, De Filippo G. Rendina D, et al. N Engl J Med. 2007 Jul 5;357(1):90-1; author reply 91. N Engl J Med. 2007. PMID: 17615641 No abstract available.

References

    1. Weber R, Sabin CA, Friis-Moller N, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006;166:1632–1641. - PubMed
    1. Salmon-Ceron D, Lewden C, Morlat P, et al. Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol. 2005;42:799–805. - PubMed
    1. Benhamou Y. Antiretroviral therapy and HIV/hepatitis B virus coinfection. Clin Infect Dis. 2004;38(Suppl 2):S98–S103. - PubMed
    1. Pol S, Lebray P, Vallet-Pichard A. HIV infection and hepatic enzyme abnormalities: intricacies of the pathogenic mechanisms. Clin Infect Dis. 2004;38(Suppl 2):S65–S72. - PubMed
    1. Powderly WG. Antiretroviral therapy in patients with hepatitis and HIV: weighing risks and benefits. Clin Infect Dis. 2004;38(Suppl 2):S109–S113. - PubMed

Publication types

MeSH terms